ArticleOncogene2021

Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.

Silvia Pietrobono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.